CTLA4 and neoplasm: Additionally, TAMs suppress anti-tumor T-cell responses, enabling immune evasion and tumor growth by secreting anti-inflammatory cytokines (IL-10, TGF-β, PGE2) and inhibiting T-cell activation through checkpoint pathways (PD-1, CTLA-4) [133,134,135].